Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cadient Acquires InterMedia Interactive's Pharmaceutical Practice.


Business Editors

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Sept. 22, 2003

Strategic Services Company Adds a Suite of Established Products to Better Serve the Sophisticated Needs of Pharmaceutical Marketing Clients

Cadient Inc. announced today that the company has acquired key pharmaceutical assets from InterMedia Intermedia - A hypertext system developed by a research group at IRIS (Brown University).  Interactive Solutions--a provider of Internet technology solutions for the pharmaceutical industry. Under the terms of the deal, Cadient, a leader in online pharmaceutical marketing, acquires IMI IMI International Masonry Institute (Washington, DC)
IMI Israel Military Industries
IMI Institute of the Motor Industry
IMI International Market Insight
IMI Imposto Municipal Sobre Imóveis (Portugal) 
 technology products and key management personnel, as well as offshore development capabilities, all designed to streamline pharmaceutical branding and optimize its commercial potential.

As part of the agreement, Cadient becomes the sole licensor of Virtual Liaison-Key Opinion Leader to the pharmaceutical industry. Virtual Liaison-Key Opinion Leader is a suite of applications that cultivates relationships with key opinion leaders and advocates whose input is instrumental in gaining clinical approval and acceptance of a new brand offering. In addition, the acquisition brings several other products, including Symposia sym·po·si·a  
n.
A plural of symposium.
 Management, a secure, virtual, real-time meeting space for conducting medical education and professional development activities, and FasTrac, a tool designed to streamline the submission and approval process of brand assets.

According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 Bob Weissman, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Cadient, Inc., "The acquisition serves as an important strategic move that dramatically increases our capacity, and greatly enhances our technology foundation. The acquisition, which is expected to add to current year revenues, aligns with Cadient's aggressive growth plan by providing a multi-dimensional offering of products, services and software."

Concurrent with the acquisition, Cadient introduces two new technology subsidiaries, Saband Technologies, which will be headed by Ashesh Shah, a founder of IMI, and Saband Asia, an offshore subsidiary that will provide additional programming capacity to both Saband and Cadient Group.

"As we evolve our products over time, Saband will benefit from the strategic expertise provided by Cadient, which will help us to develop innovative solutions for managing relationships that build brand value," says Shah. Saband's products are currently used by such brand leaders as Pfizer and Aventis.

"This potent combination of highly-specialized service and technology immediately transforms the organization into one uniquely capable of meeting the diverse and changing needs of pharmaceutical customers throughout their entire product lifecycle Product lifecycle or product life cycle is the course of a product's sales and profits over time. The five stages of each product lifecycle are product development, introduction, growth, maturity and decline. ," says Shah.

"Creating separate service and product development groups allows each organization to leverage the strengths of the other while continuing to focus on their individual missions," says Weissman. "I am thoroughly excited about the opportunities that this combination provides for Cadient and the opportunity to work shoulder-to-shoulder with Ashesh, who is one of the brightest minds in understanding how technology can positively impact pharmaceutical marketing. This acquisition lays the groundwork for Cadient to realize its goal of growing 50% per year through both organic growth and acquisition of complementary offerings."

About Cadient

A world-class online pharmaceutical marketing agency, Cadient develops and deploys precise and highly accountable online marketing programs. These programs address the behavioral patterns In software engineering, behavioral design patterns are design patterns that identify common communication patterns between objects and realize these patterns. By doing so, these patterns increase flexibility in carrying out this communication.  of consumers and health care professionals and move them to try, purchase, prescribe pre·scribe
v.
To give directions, either orally or in writing, for the preparation and administration of a remedy to be used in the treatment of a disease.
, and remain loyal to specific brands. Cadient's primary mission is to deliver demonstrative LEGACY, DEMONSTRATIVE. A demonstrative legacy is a bequest of a certain sum of money; intended for the legatee at all events, with a fund particularly referred to for its payment; so that if the estate be not the testator's property at his death, the legacy will not fail: but be payable  results for pharmaceutical companies seeking to activate consumer behavior; launch, build, and sustain Rx and OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 brands. Cadient works with many of the world's leading pharmaceutical companies, including AstraZeneca, Procter & Gamble, GlaxoSmithKline, and Johnson & Johnson.

About Saband Technologies

Saband Technologies develops technology solutions for the pharmaceutical industry that simplify the management of complex relationships. Saband designs robust technology platforms that help to coordinate the internal and external relationships and optimize workflow during the drug development cycle. Saband's products incorporate the company's knowledge of regulatory issues, HIPAA (Health Insurance Portability & Accountability Act of 1996, Public Law 104-191) Also known as the "Kennedy-Kassebaum Act," this U.S. law protects employees' health insurance coverage when they change or lose their jobs (Title I) and provides standards for patient health,  regulations, thought leader development, and the challenges of building a pharmaceutical marketing community. Saband has created solutions for pharmaceutical brand initiatives for companies including Pfizer, Aventis Pharmaceuticals, Sanofi-Synthelabo and Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. .
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 22, 2003
Words:615
Previous Article:Plexis Group and NX Communications Deliver High-Tech Hook-Up to Ruth Lilly Health Education Center.
Next Article:CytoGenix to Present at Friedland Capital's Biotech, Medical and Healthcare Conference Featuring Companies Covered by J.M. Dutton & Associates.



Related Articles
Sybase to provide multimedia software for Scientific-Atlanta's PowerTV set top boxes; Sybase's Gain Interplay to support delivery of interactive...
Intermedia Communications to Create Nationwide Customer Call Center; World-Class Customer Care is Key Initiative.
blaxxun interactive Launches U.S. Reseller Initiative With InterMedia Partnership; Agreement Turns Focus of blaxxun's Sales Initiative to U.S.,...
Do Not Call Solution For Teleservices Providers.
Management Team Purchases Qwest Communications' Online Pharmaceutical Marketing Practice.
Industry Acclaims ePharma Summit: Strategic Marketing Integration; Industry Leaders Look Forward to Premier U.S. Pharmaceutical Event.
Cadient Group Board of Directors Announces Christopher French as Interim CEO; CEO Robert Weissman Resigns.
Cadient Group Appoints Stephen Wray as President and CEO; Seasoned Pharmaceutical Marketing Executive Brings 20-Plus Years of Diverse Industry...
Workshops, recitals for low brass.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles